-
561
PARylation of HMGA1 desensitizes esophageal squamous cell carcinoma to olaparib
Published 2024-12-01Subjects: “…chemotherapy sensitivity…”
Get full text
Article -
562
A case of spindle cell squamous cell carcinoma of the tongue complicated by verrucous carcinoma
Published 2025-03-01Subjects: Get full text
Article -
563
Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas
Published 2025-01-01Subjects: Get full text
Article -
564
-
565
Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer
Published 2025-01-01Subjects: Get full text
Article -
566
Uterine endometrioid adenocarcinoma with pilomatrix-like differentiation: A case report and review of the literature
Published 2025-02-01Subjects: Get full text
Article -
567
Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review
Published 2025-02-01Subjects: Get full text
Article -
568
-
569
-
570
The adverse impact of chemo-radiotherapy on the quality of life of oral cancer patients: A review
Published 2024-06-01Subjects: Get full text
Article -
571
-
572
On viable therapy strategy for a mathematical spatial cancer model describing the dynamics of malignant and healthy cells
Published 2014-11-01Subjects: Get full text
Article -
573
-
574
-
575
-
576
Updated Bayesian network meta-analysis on the efficacy and safety of PD−1 versus PD−L1 inhibitors in first−line treatment with chemotherapy for extensive−stage small-cell lung cancer
Published 2025-01-01“…ObjectiveTo compare the efficacy and safety of programmed cell death 1 inhibitors plus chemotherapy (PD-1 + Chemo) and programmed cell death ligand 1 inhibitors plus chemotherapy (PD-L1 + Chemo) for the treatment of extensive-stage small-cell lung cancer (ES-SCLC).MethodsWe performed a meta-analysis of relevant data using R software, considering overall survival (OS), progression-free survival (PFS), and grade ≥ 3 treatment-related adverse events (TRAES).ResultsPD-1 + Chemo (OS: hazard ratio [HR] 0.71; PFS: HR 0.59) and PD-L1 + Chemo (OS: HR 0.72; PFS: HR 0.73) significantly prolonged survival and did not increase the incidence of grade ≥3 TRAEs compared with chemotherapy. …”
Get full text
Article -
577
-
578
Sonic hedgehog restrains the ubiquitin-dependent degradation of SP1 to inhibit neuronal/glial senescence associated phenotypes in chemotherapy-induced peripheral neuropathy via the TRIM25-CXCL13 axis
Published 2025-02-01“…Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication that affects an increasing number of cancer survivors. …”
Get full text
Article -
579
Clinical features and prognostic factors of pediatric Langerhans cell histiocytosis: a single-center retrospective study
Published 2025-01-01Subjects: Get full text
Article -
580
Allopregnanolone relieves paclitaxel induced mechanical hypersensitivity via inhibiting spinal cord PGE2-EP2 mediated microglia-neuron signaling
Published 2025-06-01Subjects: “…Chemotherapy-induced neuropathic pain…”
Get full text
Article